The effect of prophylactic vitamin
Children who were 6 mo of age entered the trials either at the first dosing round or at each of the subsequent rounds and exited at the last dosing round, or at the time that they moved out of the study area, died, or were withdrawn from the trial. Children with confirmed xerophthalmia were treated and excluded from the study at the time they were diagnosed.
In the Survival Study, children who moved from one cluster to another with a different treatment assignment were excluded from the study on the date they received their first dose of the different treatment. 
